HCAT Health Catalyst, Inc.

NASDAQ
$1.59

Health Catalyst, Inc. (HCAT) is confirmed to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -14.5% since its last earnings release on August 6, 2026.

Health Catalyst Missed Expectations, Lowers Guidance
Thursday, August 6, 2026 · 4:03 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
$0.01
vs ($0.02) (non-GAAP) +$0.03
Rev est $55.19M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.72

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Health Catalyst, Inc.

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.

Sector

Technology

Industry

Business Software and Services

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.